October 7, 2009 – GE Healthcare this week said the FDA cleared the CARESCAPE Monitor B850, which the company said provides caregivers with a new level of integration between patient monitoring data and hospital information systems, because it directly links hospital networks, electronic medical records (EMRs), diagnostic images, lab results and third-party devices with real-time patient monitoring data, to support efficient clinical decision-making.
This enables CARESCAPE Monitor B850 to integrate its continuous clinical measurements with other elements of the patient record, delivering it at the point of care. GE healthcare said the device brings together the strong clinical heritage of Datex-Ohmeda’s anesthesia and Marquette Electronics’ cardiac expertise. It provides customized clinical information displays by care area and clinician preference, while also enabling hospitals to standardize on a monitoring platform throughout the organization. Developed with thousands of hours of field and in-house testing, the CARESCAPE Monitor B850 is the latest product in the GE Healthcare CARESCAPE portfolio, designed to deliver streamlined access to critical patient information for enhanced decision making.
Traditionally, when a patient experiences chest pain, a caregiver must find and move an ECG machine from a different location to the patient’s bedside. The CARESCAPE Monitor B850 not only enables “cart-less” diagnostic ECGs at the bedside, but also exchanges data with the MUSE ECG repository, facilitating ECG analysis and comparisons to the patient’s prior ECG, supporting more informed clinical decisions.
Anesthesia clinicians have historically administered anesthetics without real-time, integrated anesthetic management tools because anesthesia delivery and patient monitoring systems are often ineffectively integrated. GE Navigator Applications Suite combined with CARESCAPE Monitor B850 analyzes drug therapy information to model and predict the effect of anesthesia-related drugs and drug interactions. This enables clinicians to visualize modeled anesthetic drug effect predictions against live patient data, which supports patient tailored anesthesia.
The CARESCAPE Monitor B850 also enables bedside viewing of hospital EMRs, as well as x-rays, labs and other diagnostic reports, including the associated diagnoses from the hospital’s experts. This quick, comprehensive view of the patient’s records encourages confidence as clinicians make critical decisions at the point of care.
For more information: www.gehealthcare.com
March 06, 2026 
